Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations.
about
Drugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risksThe risk of congenital malformations associated with exposure to β-blockers early in pregnancy: a meta-analysis.Adenylyl cyclase signaling in the developing chick heart: the deranging effect of antiarrhythmic drugsHypertension in women of reproductive age in the United States: NHANES 1999-2008.Patterns of outpatient antihypertensive medication use during pregnancy in a Medicaid population.Drugs in pregnancy: Implications for a cardiologist.Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort studyMaternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study.Case-control analysis of maternal prenatal analgesic use and cardiovascular malformations: Baltimore-Washington Infant StudyIs maternal parity an independent risk factor for birth defects?Trends in pre-pregnancy diabetes among deliveries in 19 U.S. states, 2000-2010.Maternal Hypertension During Pregnancy and the Risk of Congenital Heart Defects in Offspring: A Systematic Review and Meta-analysis.Are hypertensive disorders in pregnancy associated with congenital malformations in offspring? Evidence from the WHO Multicountry cross sectional survey on maternal and newborn health.Factors associated with major structural birth defects among newborns delivered at Muhimbili National Hospital and Municipal Hospitals in Dar Es Salaam, Tanzania 2011 - 2012.Use of antiepileptic medications in pregnancy in relation to risks of birth defectsReversible Fetal Renal Impairment following Angiotensin Receptor Blocking Treatment during Third Trimester of Pregnancy: Case Report and Review of the Literature.Association of maternal chronic disease with risk of congenital heart disease in offspringHypertension complicating diabetic pregnancies: pathophysiology, management, and controversies.The pathogenesis of atrial and atrioventricular septal defects with special emphasis on the role of the dorsal mesenchymal protrusion.Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence.Nongenetic risk factors and congenital heart defects.Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits.SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014.In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review.Atrial fibrillation in pregnancy: a growing challenge.The changing epidemiology of Ebstein's anomaly and its relationship with maternal mental health conditions: a European registry-based study.Renin-Angiotensin System Blocker Fetopathy.Antihypertensive drugs and the risk of congenital anomalies.Fetal risk from angiotensin converting enzyme inhibitors in the first trimester.Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies: A European Case-Malformed Control Study.The effects of poor maternal nutrition during gestation on postnatal growth and development of lambs.Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials.Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection.Angiotensin receptor blockade in diabetic women of childbearing potential: an acceptable risk?Analysis of selected maternal exposures and non-syndromic atrioventricular septal defects in the National Birth Defects Prevention Study, 1997-2005.Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control studyMaternal hypertension and risk for hypospadias in offspring
P2860
Q26991704-0E7344C2-9BB3-40D7-BDC2-892DA5B19B1BQ33863487-6ADF8B8E-8C4D-47E7-B508-B5E9ABB21CB2Q33876726-341B5316-F1C9-4F8D-A4C0-669A6E92FFB4Q34257254-5BDA4D4B-CCF1-400F-BFEA-187C767AB220Q34298992-3EC31E9B-BF0B-499A-9195-F00FD9A5C06EQ34467069-3632017D-8249-4F4D-A4EF-1B9BEB928C2CQ35137516-F084E82B-A463-4A42-9555-563F71E0687BQ35384541-4063B521-4215-4D1B-B724-ED34B96DEBA4Q35525008-2C080C68-1DC8-4AE3-A1A8-67800A6661F6Q35764608-69D19E50-CFF4-4ABC-98F8-A6725F13AF64Q35800081-A1DF5ABE-4FE4-47AA-B6EC-F26E069E523BQ36069029-E143D6B5-E33B-4387-A01E-57A579AA3C29Q36090080-41FD43E9-DE8E-4215-8966-EFA8F6FA68B9Q36185730-BF21CA5E-C307-45BA-A2E1-CB066ADF8D77Q36751405-321FB52F-19A0-4375-8C2C-E4DB72E0BB9CQ37273818-26F7C468-3DC6-4B29-A03A-A3386D52C051Q37470027-1EE0CA4B-B1FE-4230-8C12-8C7402E8430FQ37861890-7BDEF2D4-98BA-4011-86CE-99722943010BQ38019645-ACB61495-E6F8-48C9-B25C-17B0E53B542EQ38027126-A19469D6-37F4-43CA-8DD9-47B97F268654Q38130429-2AF0D2CF-6EFF-4246-84D0-F40C0FFF7138Q38328807-233C1A8A-B5CB-4952-93D4-444327E8B22AQ38594110-B87BE497-779F-448B-A92E-C5398E0652ECQ38702465-D5434109-14CE-4665-912B-3D1FCB7C40F4Q38789706-E2487DA5-1442-4E83-8597-1BA8FAD75BF2Q39442897-BF9003BE-ED27-4870-946C-D39C052E4BC8Q43195095-D0CF5A46-6A4C-4AE6-AF47-06EE54749B03Q46254956-DE8C74CA-A9DE-4B01-A544-14C1DEAAC5E0Q47133526-2DE2DB65-4041-4222-98BC-76B75B8E258BQ47325847-975BF7E1-170E-4C06-A085-18F2CF993EC8Q47436830-71BBC0B9-A758-4701-964D-A93F93A33DAAQ47839950-2B572D72-ADBE-44C0-B515-AF69A6920183Q53107393-123B1B83-119E-4487-9C92-8330069BB422Q54254904-39537312-10B0-4C66-AD1D-B85A17B1547FQ55686874-47ABE9EC-3AEA-467A-8E49-62CA12AC4AC0Q58934061-78ACE13F-23A5-4CE4-9F62-2EDFDCA05BF3Q59192482-187DC592-9632-4A09-8E51-4A0C7E18E008
P2860
Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antihypertensive medication us ...... cardiovascular malformations.
@en
Antihypertensive medication us ...... cardiovascular malformations.
@nl
type
label
Antihypertensive medication us ...... cardiovascular malformations.
@en
Antihypertensive medication us ...... cardiovascular malformations.
@nl
prefLabel
Antihypertensive medication us ...... cardiovascular malformations.
@en
Antihypertensive medication us ...... cardiovascular malformations.
@nl
P2093
P2860
P50
P1433
P1476
Antihypertensive medication us ...... cardiovascular malformations.
@en
P2093
Adolfo Correa
Alissa R Caton
Angela E Lin
Charlotte M Druschel
Erin M Bell
Louise-Anne McNutt
Marilyn L Browne
Richard S Olney
P2860
P356
10.1161/HYPERTENSIONAHA.109.129098
P407
P577
2009-05-11T00:00:00Z